Phar Vision Advisers, LLC Cv Rx, Inc. Transaction History
Phar Vision Advisers, LLC
- $118 Billion
- Q4 2024
A detailed history of Phar Vision Advisers, LLC transactions in Cv Rx, Inc. stock. As of the latest transaction made, Phar Vision Advisers, LLC holds 20,480 shares of CVRX stock, worth $302,489. This represents 0.22% of its overall portfolio holdings.
Number of Shares
20,480Holding current value
$302,489% of portfolio
0.22%Shares
1 transactions
Others Institutions Holding CVRX
# of Institutions
95Shares Held
15.4MCall Options Held
76.5KPut Options Held
6.3K-
Johnson & Johnson New Brunswick, NJ4.1MShares$60.6 Million17.73% of portfolio
-
Nea Management Company, LLC Timonium, MD2.03MShares$29.9 Million1.83% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT921KShares$13.6 Million1.7% of portfolio
-
Vanguard Group Inc Valley Forge, PA910KShares$13.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY876KShares$12.9 Million0.0% of portfolio
About CVRx, Inc.
- Ticker CVRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 20,576,200
- Market Cap $304M
- Description
- CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...